Reactions of [{bis(2-pyridylmethyl)amine}trichloroiron(III)] with (HOCH2)3CNHCO(CH2)nCONHC(CH2OH)3 (n=0−2): crystal structures of (μ-oxo)bis{(oxalato){[bis(pyridylmethyl)amine]iron(III)} and (HOCH2)3CNHCO(CH2)2CONHC(CH2OH)3
作者:Christiane Fernandes、James L. Wardell、Adolfo Horn、Janet M.S. Skakle、Valderes Drago
DOI:10.1016/j.poly.2004.02.027
日期:2004.5
H)3, (1: n=0) or HO2CCO2H in basic media, are reported: BMPA=bis-(2-pyridylmethyl)amine; ox=oxalato. Each iron centre in 4 is coordinated to all three nitrogen atoms of a BMPA ligand, to two oxygen atoms from a chelating oxalato ligand and to a bridging oxide linking the two metals. The central Fe–O–Fe bond in centrosymmetric 4 is linear. The Fe(III) centres have distorted octahedral geometries with
Design and Synthesis of “Dumb-bell” and “Triangular” Inorganic-Organic Hybrid Nanopolyoxometalate Clusters and Their Characterisation through ESI-MS Analyses
作者:Chullikkattil P. Pradeep、Feng-Yan Li、Claire Lydon、Haralampos N. Miras、De-Liang Long、Lin Xu、Leroy Cronin
DOI:10.1002/chem.201100257
日期:2011.6.27
linear (bis(TRIS)) and triangular (tris(TRIS)) ligands has been synthesised and were covalently attached to the Wells–Dawson type cluster [P2V3W15O62]9− to generate a series of nanometer‐sized inorganic–organichybrid polyoxometalate clusters. These huge hybrids, with a molecular mass similar to that of small proteins in the range of ≈10–16 kDa, were unambiguously characterised by using high‐resolution
合成了一系列基于三(羟甲基)氨基甲烷(TRIS)的线性(bis(TRIS))和三角形(tris(TRIS))配体,它们共价连接至Wells-Dawson型簇[P 2 V 3 W 15 O 62 ] 9−生成一系列纳米尺寸的无机-有机杂多金属氧酸盐簇。这些巨大的杂种,其分子质量与小蛋白相似,在≈10-16kDa范围内,使用高分辨率ESI-MS进行了明确鉴定。这些化合物的ESI-MS谱揭示,在负离子模式下,特征模式示出对应于不同的阴离子的电荷状态为3峰的不同组- 8 -对于混合动力车。这些单独组中的每个峰都可以明确地分配给带有四丁基铵(TBA)和其他阳离子的不同组合的相应杂化簇阴离子。因此,本研究强调了高分辨率ESI-MS的卓越能力,可以对质量为10–16 kDa的大规模,纳米级,无机-有机杂化团簇进行明确的表征。同样,这些化合物的设计合成表明,我们能够通过配体设计路线在合成这些无机-有机杂多
US5709737A
申请人:——
公开号:US5709737A
公开(公告)日:1998-01-20
Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
申请人:ADOCIA
公开号:US20160082106A1
公开(公告)日:2016-03-24
A composition, in the form of an aqueous solution, including insulin in hexameric form, at least one substituted anionic compound of non-saccharide structure and at least one polyanionic compound other than the substituted anionic compound.